XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Grants Valuation Assumptions The relevant data used to determine the fair value of the stock option grants during the years ended December 31, 2023 and 2022 is as follows, presented on a weighted-average basis:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Risk-free interest rate

 

 

4.0

%

 

 

3.2

%

Expected volatility

 

 

78.4

%

 

 

78.1

%

Expected dividend yield

 

 

 

 

 

 

Expected term (in years)

 

 

5.8

 

 

 

6.1

 

Schedule of Stock Options Activity

The following table summarizes the Company’s option activity since December 31, 2023:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Number of Shares

 

 

Price

 

 

Term

 

 

Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2023

 

 

2,319,725

 

 

$

13.63

 

 

 

6.01

 

 

$

6,939

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(457,210

)

 

 

7.77

 

 

 

 

 

 

 

Forfeited

 

 

(308,859

)

 

 

40.08

 

 

 

 

 

 

 

Outstanding as of December 31, 2024

 

 

1,553,656

 

 

$

10.09

 

 

 

5.71

 

 

$

15,382

 

Vested and expected to vest as of
    December 31, 2024

 

 

1,553,656

 

 

$

10.09

 

 

 

5.71

 

 

$

15,382

 

Options exercisable as of December 31, 2024

 

 

1,114,324

 

 

$

9.92

 

 

 

4.83

 

 

$

11,222

 

Summary of Stock-Based Compensation Expense of Statements of Operations and Comprehensive Loss

The Company recorded stock-based compensation expense in the following expense categories of its statements of operations and comprehensive income (loss) (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Cost of revenue

 

$

182

 

 

$

219

 

 

$

281

 

Sales and marketing

 

 

6,796

 

 

 

8,667

 

 

 

11,018

 

Research and development

 

 

5,502

 

 

 

8,053

 

 

 

10,328

 

General and administrative

 

 

8,134

 

 

 

5,869

 

 

 

7,359

 

Restructuring and other charges

 

 

 

 

 

1,288

 

 

 

 

 

$

20,614

 

 

$

24,096

 

 

$

28,986

 

Service-Based RSUs  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Unvested Restricted Stock Units

The following table summarizes the Company’s RSU with service-based vesting conditions activity since December 31, 2023:

 

 

 

 

 

Weighted Average

 

 

Number of Shares

 

 

Grant-Date Fair Value

 

Unvested balance December 31, 2023

 

 

2,086,007

 

 

$

12.29

 

Granted

 

 

1,302,166

 

 

 

18.24

 

Vested

 

 

(1,099,807

)

 

 

13.12

 

Forfeited

 

 

(209,121

)

 

 

16.30

 

Unvested balance December 31, 2024

 

 

2,079,245

 

 

$

15.17

 

Service and Performance Based RSUs  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Unvested Restricted Stock Units

The following table summarizes the Company’s RSU with both service-based vesting and performance-based vesting conditions activity since December 31, 2023:

 

 

 

 

 

Weighted Average

 

 

 

Number of Shares

 

 

Grant-Date Fair Value

 

Unvested balance December 31, 2023

 

 

 

 

$

 

Granted

 

 

327,075

 

 

 

15.58

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Unvested balance December 31, 2024

 

 

327,075

 

 

$

15.58